Tune Therapeutics

  • BioTech/Drugs
  • Durham NC
  • 89 employees
Get Full Info

Company Overview

Website
tunetx.com
Employees
89
Industry
BioTech/Drugs
SIC Code
8731 - Commercial Physical and Biological Research
More Details

Financials & Stats

Revenue

$50B

More Financials

Recent News & Media

Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board

  • Mar 4, 2025
  • businesswire.com

Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials

  • Jan 30, 2025
  • dukechronicle.com

Durham biotech startup raises $175 million as it starts novel gene therapy trial

  • Jan 14, 2025
  • newsobserver.com

Epigenetic biotech raises bumper round to the Tune of $175M to fund entry into clinic

  • Jan 13, 2025
  • fiercebiotech.com

Durham biotech firm Tune Therapeutics has raised a $175 million funding round

  • Jan 13, 2025
  • axios.com

Tune raises $175M for hepatitis B medicine, epigenetic research

  • Jan 12, 2025
  • biopharmadive.com

Who is Tune Therapeutics

Tune Therapeutics, a biotechnology company headquartered in Durham, North Carolina, employs 89 individuals. Founded in the United States, Tune Therapeutics specializes in developing innovative epigenomic therapies. Tune Therapeutics focuses on pioneering epi-therapeutic medicines using its proprietary TEMPO platform. TEMPO allows for precise control over gene expression, effectively "tuning" gene activity toward healthy levels without altering DNA permanently. This unique approach targets multiple genes simultaneously, offering the potential to reverse pathways associated with cancer, genetic diseases, and aging. Their genetic tuning technology expands the possibilities of genetic medicine, addressing a broader spectrum of diseases, including complex and chronic conditions lacking curative treatments. For inquiries, interested parties can visit Tune Therapeutics' website at tuntx.com.

Company Leadership

Shannon Grace

Executive Assistant To Chief Executive Officer & Leadership Team

Phone Email
Matt Kane

Chief Executive Officer

Phone Email
Charles Gersbach

Co-Founder

Phone Email
Fyodor Urnov

Co-Founder

Phone Email
Stephanie Bolton

Vice President, Human Resources

Phone Email

Companies Similar to Tune Therapeutics

Analyze industry trends and opportunities by examining competitors and companies comparable to Tune Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
50M Cambridge, MA
50M 24 Cambridge, MA
50M 68 Cambridge, MA 2000
50M 7 Boston, MA 2006
50M 225 Boston, MA 2002
View More Companies

FAQ

What is the location of Tune Therapeutics's headquarters?
The headquarters of Tune Therapeutics are situated at 300 Morris St, Suite 320, Durham NC
What is Tune Therapeutics's official website?
The official website of Tune Therapeutics can be found at tunetx.com.
What is Tune Therapeutics's current revenue?
As of April 2023, Tune Therapeutics's annual revenue reached $50B.
How many employees does Tune Therapeutics currently have?
Tune Therapeutics employs approximately 89+ people as of April 2023
Which industries is Tune Therapeutics primarily operating in?
Tune Therapeutics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the Executive Assistant To Chief Executive Officer & Leadership Team of Tune Therapeutics?
Tune Therapeutics's Executive Assistant To Chief Executive Officer & Leadership Team is Shannon Grace

Employee Directory

Key Employees

Akira Matsuno

Co-Founder, President & CFO

Phone Email

Haley Peper

Senior Project Manager

Phone Email

Lena Badicke

Lab Assistant - Facilities & Lab Operations

Phone Email

Blythe Sather

VP, Head of Research

Phone Email

Andrew Spreckman

Process Engineer/Scientist

Phone Email